Position in RNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,122,970
New position
Shares Held
607,552
first reported quarter
Ownership
3.55%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026TIG Advisors, LLC holds $242,393,487 across 8 Biotechnology names. RNA ranks #7 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACLX |
Arcellx, Inc.
|
541,378 | $62,161,021 | |
| 2 | FOLD |
AMICUS THERAPEUTICS, INC.
|
3,825,445 | $55,315,934 | |
| 3 | APLS |
Apellis Pharmaceuticals, Inc.
|
1,252,986 | $50,407,626 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
511,191 | $26,949,989 | |
| 5 | CNTA |
Centessa Pharmaceuticals plc
|
648,326 | $25,751,508 | |
| 6 | DAWN |
Day One Biopharmaceuticals, Inc.
|
613,918 | $13,162,401 | |
| 7 | RNA |
Atrium Therapeutics, Inc.
This page
|
607,552 | $8,122,970 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
5,368 | $522,038 |
All Filings in RNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,122,970 | 607,552 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||